98 research outputs found
Recommended from our members
IMPROVED BIOMASS UTILIZATION THROUGH REMOTE FLOW SENSING
The growth of the livestock industry provides a valuable source of affordable, sustainable, and renewable bioenergy, while also requiring the safe disposal of the large quantities of animal wastes (manure) generated at dairy, swine, and poultry farms. If these biomass resources are mishandled and underutilized, major environmental problems will be created, such as surface and ground water contamination, odors, dust, ammonia leaching, and methane emission. Anaerobic digestion of animal wastes, in which microorganisms break down organic materials in the absence of oxygen, is one of the most promising waste treatment technologies. This process produces biogas typically containing {approx}65% methane and {approx}35% carbon dioxide. The production of biogas through anaerobic digestion from animal wastes, landfills, and municipal waste water treatment plants represents a large source of renewable and sustainable bio-fuel. Such bio-fuel can be combusted directly, used in internal combustion engines, converted into methanol, or partially oxidized to produce synthesis gas (a mixture of hydrogen and carbon monoxide) that can be converted to clean liquid fuels and chemicals via Fischer-Tropsch synthesis. Different design and mixing configurations of anaerobic digesters for treating cow manure have been utilized commercially and/or tested on a laboratory scale. These digesters include mechanically mixed, gas recirculation mixed, and slurry recirculation mixed designs, as well as covered lagoon digesters. Mixing is an important parameter for successful performance of anaerobic digesters. It enhances substrate contact with the microbial community; improves pH, temperature and substrate/microorganism uniformity; prevents stratification and scum accumulation; facilitates the removal of biogas from the digester; reduces or eliminates the formation of inactive zones (dead zones); prevents settling of biomass and inert solids; and aids in particle size reduction. Unfortunately, information and findings in the literature on the effect of mixing on anaerobic digestion are contradictory. One reason is the lack of measurement techniques for opaque systems such as digesters. Better understanding of the mixing and hydrodynamics of digesters will result in appropriate design, configuration selection, scale-up, and performance, which will ultimately enable avoiding digester failures. Accordingly, this project sought to advance the fundamental knowledge and understanding of the design, scale up, operation, and performance of cow manure anaerobic digesters with high solids loading. The project systematically studied parameters affecting cow manure anaerobic digestion performance, in different configurations and sizes by implementing computer automated radioactive particle tracking (CARPT), computed tomography (CT), and computational fluid dynamics (CFD), and by developing novel multiple-particle CARPT (MP-CARPT) and dual source CT (DSCT) techniques. The accomplishments of the project were achieved in a collaborative effort among Washington University, the Oak Ridge National Laboratory, and the Iowa Energy Center teams. The following investigations and achievements were accomplished: Systematic studies of anaerobic digesters performance and kinetics using various configurations, modes of mixing, and scales (laboratory, pilot plant, and commercial sizes) were conducted and are discussed in Chapter 2. It was found that mixing significantly affected the performance of the pilot plant scale digester ({approx}97 liter). The detailed mixing and hydrodynamics were investigated using computer automated radioactive particle tracking (CARPT) techniques, and are discussed in Chapter 3. A novel multiple particle tracking technique (MP-CARPT) technique that can track simultaneously up to 8 particles was developed, tested, validated, and implemented. Phase distribution was investigated using gamma ray computer tomography (CT) techniques, which are discussed in Chapter 4. A novel dual source CT (DSCT) technique was developed to measure the phase distribution of dynamic three phase system such as digesters with high solids loading and other types of gas-liquid-solid fluidization systems. Evaluation and validation of the computational fluid dynamics (CFD) models and closures were conducted to model and simulate the hydrodynamics and mixing intensity of the anaerobic digesters (Chapter 5). It is strongly recommended that additional studies be conducted, both on hydrodynamics and performance, in large scale digesters. The studies should use advanced non-invasive measurement techniques, including the developed novel measurement techniques, to further understand their design, scale-up, performance, and operation to avoid any digester failure. The final goal is a system ready to be used by farmers on site for bioenergy production and for animal/farm waste treatment
Regulation and Repair of the Alveolar-Capillary Barrier in Acute Lung Injury
Considerable progress has been made in understanding the basic mechanisms that regulate fluid and protein exchange across the endothelial and epithelial barriers of the lung under both normal and pathological conditions. Clinically relevant lung injury occurs most commonly from severe viral and bacterial infections, aspiration syndromes, and severe shock. The mechanisms of lung injury have been identified in both experimental and clinical studies. Recovery from lung injury requires the reestablishment of an intact endothelial barrier and a functional alveolar epithelial barrier capable of secreting surfactant and removing alveolar edema fluid. Repair mechanisms include the participation of endogenous progenitor cells in strategically located niches in the lung. Novel treatment strategies include the possibility of cell-based therapy that may reduce the severity of lung injury and enhance lung repair
A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): bluetongue
Non peer reviewe
Antigen-Specific Blocking of CD4-Specific Immunological Synapse Formation Using BPI and Current Therapies for Autoimmune Diseases
This is the peer reviewed version of the following article: Manikwar, P., Kiptoo, P., Badawi, A. H., BΓΌyΓΌktimkin, B. and Siahaan, T. J. (2012), Antigen-specific blocking of CD4-Specific immunological synapse formation using BPI and current therapies for autoimmune diseases. Med Res Rev, 32: 727β764. doi:10.1002/med.20243, which has been published in final form at http://doi.org/10.1002/med.20243. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.In this review, we discuss T-cell activation, etiology, and the current therapies of autoimmune diseases (i.e., MS, T1D, and RA). T-cells are activated upon interaction with antigen-presenting cells (APC) followed by a βbullβs eyeβ-like formation of the immunological synapse (IS) at the T-cellβAPC interface. Although the various disease-modifying therapies developed so far have been shown to modulate the IS and thus help in the management of these diseases, they are also known to present some undesirable side effects. In this study, we describe a novel and selective way to suppress autoimmunity by using a bifunctional peptide inhibitor (BPI). BPI uses an intercellular adhesion molecule-1 (ICAM-1)-binding peptide to target antigenic peptides (e.g., proteolipid peptide, glutamic acid decarboxylase, and type II collagen) to the APC and therefore modulate the immune response. The central hypothesis is that BPI blocks the IS formation by simultaneously binding to major histocompatibility complex-II and ICAM-1 on the APC and selectively alters the activation of T cells from TH1 to Treg and/or TH2 phenotypes, leading to tolerance
Mechanism of cellular rejection in transplantation
The explosion of new discoveries in the field of immunology has provided new insights into mechanisms that promote an immune response directed against a transplanted organ. Central to the allograft response are T lymphocytes. This review summarizes the current literature on allorecognition, costimulation, memory T cells, T cell migration, and their role in both acute and chronic graft destruction. An in depth understanding of the cellular mechanisms that result in both acute and chronic allograft rejection will provide new strategies and targeted therapeutics capable of inducing long-lasting, allograft-specific tolerance
Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches
History of clinical transplantation
The emergence of transplantation has seen the development of increasingly potent immunosuppressive agents, progressively better methods of tissue and organ preservation, refinements in histocompatibility matching, and numerous innovations is surgical techniques. Such efforts in combination ultimately made it possible to successfully engraft all of the organs and bone marrow cells in humans. At a more fundamental level, however, the transplantation enterprise hinged on two seminal turning points. The first was the recognition by Billingham, Brent, and Medawar in 1953 that it was possible to induce chimerism-associated neonatal tolerance deliberately. This discovery escalated over the next 15 years to the first successful bone marrow transplantations in humans in 1968. The second turning point was the demonstration during the early 1960s that canine and human organ allografts could self-induce tolerance with the aid of immunosuppression. By the end of 1962, however, it had been incorrectly concluded that turning points one and two involved different immune mechanisms. The error was not corrected until well into the 1990s. In this historical account, the vast literature that sprang up during the intervening 30 years has been summarized. Although admirably documenting empiric progress in clinical transplantation, its failure to explain organ allograft acceptance predestined organ recipients to lifetime immunosuppression and precluded fundamental changes in the treatment policies. After it was discovered in 1992 that long-surviving organ transplant recipient had persistent microchimerism, it was possible to see the mechanistic commonality of organ and bone marrow transplantation. A clarifying central principle of immunology could then be synthesized with which to guide efforts to induce tolerance systematically to human tissues and perhaps ultimately to xenografts
- β¦